Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 21:6:9.
doi: 10.3389/fnsyn.2014.00009. eCollection 2014.

Serine racemase: a key player in apoptosis and necrosis

Affiliations
Review

Serine racemase: a key player in apoptosis and necrosis

Nadia Canu et al. Front Synaptic Neurosci. .

Abstract

A fine balance between cell survival and cell death is required to sculpt the nervous system during development. However, an excess of cell death can occur following trauma, exposure to neurotoxins or alcohol, and some developmental and neurodegenerative diseases, such as Alzheimer's disease (AD). N-Methyl-D-aspartate receptors (NMDARs) support synaptic plasticity and survival of many neuronal populations whereas inappropriate activation may promote various forms of cell death, apoptosis, and necrosis representing the two extremes of a continuum of cell death processes both "in vitro" and "in vivo." Hence, by identifying the switches controlling pro-survival vs. apoptosis and apoptosis vs. pro-excitotoxic outcome of NMDAR stimulation, NMDAR modulators could be developed that selectively block the cell death enhancing pro-survival signaling or synaptic plasticity mediated by NMDAR. Among these modulators, a role is emerging for the enzyme serine racemase (SR) that synthesizes D-serine, a key co-agonist with glutamate at NMDAR. This review summarizes the experimental evidence from "in vitro" neuronal cultures-with special emphasis on cerebellar granule neurons (CGNs)-and "in vivo" models of neurodegeneration, where the dual role of the SR/D-serine pathway as a master regulator of apoptosis and the apoptosis-necrosis shift will be discussed.

Keywords: D-serine; NMDAR; apoptosis-necrosis shift; neurodegeneration; neurological disorders; review; serine racemase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reactions catalyzed by serine racemase: (A) racemization; (B) α, β-elimination. Lys56 of SR binds the PLP cofactor, forming an internal aldimine; then SR reacts with L-serine to yield an external aldimine; α-proton abstraction from this intermediate gives a resonance-stabilized carbanion. Two alternative pathways are possible starting from this intermediate (see text for details).
Figure 2
Figure 2
Scheme illustrating the main pro-survival and pro-death signals triggered by NMDAR activity.
Figure 3
Figure 3
Dimeric structure of human SR and details of the active site. PLP is shown in orange, malonate in red, and Mn2+ as red sphere.

References

    1. Adams S. M., de Rivero Vaccari J. C., Corriveau R. A. (2004). Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J. Neurosci. 24, 9441–9450 10.1523/JNEUROSCI.3290-04.2004 - DOI - PMC - PubMed
    1. Akbulut K. G., Guney S., Cetin F., Agun H. N., Aktas S. H., Akbulut H. (2013). Melatonin delays brain aging by decreasing the nitric oxide level. Neurophysiology 45, 187–192 10.1007/s11062-013-9368-3 - DOI
    1. Alavez S., Blancas S., Morán J. (2006). Effect of NMDA antagonists on the death of cerebellar granule neurons at different ages. Neurosci. Lett. 398, 241–245 10.1016/j.neulet.2006.01.002 - DOI - PubMed
    1. Amadoro G., Ciotti M. T., Costanzi M., Cestari V., Calissano P., Canu N. (2006). NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl. Acad. Sci. U.S.A. 103, 2892–2897 10.1073/pnas.0511065103 - DOI - PMC - PubMed
    1. Amadoro G., Serafino A. L., Barbato C., Ciotti M. T., Sacco A., Calissano P., et al. (2004). Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ. 11, 217–230 10.1038/sj.cdd.4401314 - DOI - PubMed